Epstein Secrets

n of costs from our business. Our 2014 guidance reflects our confidence in achieving at least $20 million of these costs savings in 2014," added Dr. Berger. Dr. Berger continued, "Our guidance also incorporates what we are projecting to be a soft first quarter in 2014 due to the unusually severe winter

014 & 4.1x by wend 2015 ' As RDNT de-levers given its sliver of equity ($120m mkt cap) vs. its net debt balance ($587m post refi) every 0.5x chg in ebitda multiple adds $1.40/share to RDNT ' Over the past decade RDNT has been valued @ an avg 7x ebitda ' RDNT is presently valued @ 5.8x 2014 ebitda Ft 5.1x fwd ebitda ' As

of costs from our business. Our 2014 guidance reflects our confidence in achieving at least $20 million of these costs savings in 2014," added Dr. Berger. Dr. Berger continued, "Our guidance also incorporates what we are projecting to be a soft first quarter in 2014 due to the unusually severe winter

14 a 4.1x by yrend 2015 ' As RDNT de-levers given its sliver of equity ($120m mkt cap) vs. its net debt balance ($587m post refi) every 0.5x chg in ebitda multiple adds $1.40/share to RDNT ' Over the past decade RDNT has been valued @ an avg 7x ebitda • RDNT is presently valued @ 5.8x 2014 ebitda a 5.1x fwd ebitda As co

n of costs from our business. Our 2014 guidance reflects our confidence in achieving at least $20 million of these costs savings in 2014," added Dr. Berger. Dr. Berger continued, "Our guidance also incorporates what we are projecting to be a soft first quarter in 2014 due to the unusually severe winter

14 a 4.1x by yrend 2015 ' As RDNT de-levers given its sliver of equity ($120m mkt cap) vs. its net debt balance ($587m post refi) every 0.5x chg in ebitda multiple adds $1.40/share to RDNT ' Over the past decade RDNT has been valued @ an avg 7x ebitda ▪ RDNT is presently valued @ 5.8x 2014 ebitda a 5.1x fwd ebitda ' As